Literature DB >> 3019295

Hemodynamic effects of dibutyryl cyclic GMP in anesthetized dogs.

K Imura, K Ogawa, T Satake.   

Abstract

Dibutyryl cyclic GMP was given intravenously to anesthetized dogs with doses of 0.0625, 0.125, 0.25, 0.5 and 1.0 mg/kg, respectively. It induced decreases in blood pressure, heart rate, max LV dp/dt and total peripheral resistance with increase of stroke volume in a dose-dependent manner. Although these effects began to appear 30 sec after the administration in each dose, the duration of the effect was observed 50 sec after the administration. Effects of 1 mg/kg dibutyryl cyclic GMP on mean blood pressure and max LV dp/dt were almost equal to those of 3 micrograms/kg acetylcholine, but dibutyryl cyclic GMP was revealed to have a slower onset and longer acting effects than acetylcholine. The administration of atropine did not block the effect of dibutyryl cyclic GMP but blocked those of acetylcholine. These results indicate that dibutyryl cyclic GMP does not exert these effects through muscarinic receptors in spite of its acetylcholine-like effects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019295     DOI: 10.1007/bf01907410

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  12 in total

1.  Isolation of adenosine 3', 5'-monophosphate and guanosine 3', 5'-monophosphate from rat urine.

Authors:  D F ASHMAN; R LIPTON; M M MELICOW; T D PRICE
Journal:  Biochem Biophys Res Commun       Date:  1963-05-22       Impact factor: 3.575

2.  Cyclic nucleotides and the contraction of smooth muscle.

Authors:  R Andersson; K Nilsson; J Wikberg; S Johansson; E Mohme-Lundholm; L Lundholm
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

3.  Does cyclic GMP mediate the negative inotropic effect of acetylcholine in the heart?

Authors:  H Nawrath
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

4.  Cyclic AMP and cyclic GMP may play opposing roles in influencing force of contraction in mammalian myocardium.

Authors:  H Nawrath
Journal:  Nature       Date:  1976-08-05       Impact factor: 49.962

Review 5.  Parasympathetic control of the heart.

Authors:  C B Higgins; S F Vatner; E Braunwald
Journal:  Pharmacol Rev       Date:  1973-03       Impact factor: 25.468

6.  Cyclic nucleotide-dependent protein kinases. X. An assay method for the measurement of quanosine 3',5'-monophosphate in various biological materials and a study of agents regulating its levels in heart and brain.

Authors:  J F Kuo; T P Lee; P L Reyes; K G Walton; T E Donnelly; P Greengard
Journal:  J Biol Chem       Date:  1972-01-10       Impact factor: 5.157

7.  Determination of guanosine 3',5'-monophosphate in tissues and of guanyl cyclase in rat intestine.

Authors:  E Ishikawa; S Ishikawa; J W Davis; E W Sutherland
Journal:  J Biol Chem       Date:  1969-12-10       Impact factor: 5.157

8.  Role of muscarinic cholinergic receptors in regulation of guanosine 3':5'-cyclic monophosphate content in mammalian brain, heart muscle, and intestinal smooth muscle.

Authors:  T P Lee; J F Kuo; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

9.  Noncompetitive catecholamine-antagonism of acetylcholine in the sympathectomized mammalian ventricular myocardium.

Authors:  M Schwegler; K Reutter; G Sieber; R Jacob
Journal:  Basic Res Cardiol       Date:  1976 Jul-Aug       Impact factor: 17.165

10.  Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle.

Authors:  R A Keith; A M Burkman; T D Sokoloski; R H Fertel
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.